Quick Answer
ORTHOPEDIATRICS CORP reported Diluted EPS of $1.69 per share (loss) for fiscal year 2025.
ORTHOPEDIATRICS CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.69 | -3.0% |
| 2024 | -$1.64 | -78.3% |
| 2023 | -$0.92 | -1633.3% |
| 2022 | $0.06 | +107.1% |
| 2021 | -$0.84 | +53.8% |
| 2020 | -$1.82 | -93.6% |
| 2019 | -$0.94 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.50 | -47.1% | -66.7% |
| June 30, 2025 | -$0.30 | -15.4% | +34.8% |
| March 31, 2025 | -$0.46 | -35.3% | -35.3% |
| September 30, 2024 | -$0.34 | -70.0% | -30.8% |
| June 30, 2024 | -$0.26 | -100.0% | +23.5% |
| March 31, 2024 | -$0.34 | -13.3% | -70.0% |
| September 30, 2023 | -$0.20 | -123.0% | -53.8% |
| June 30, 2023 | -$0.13 | -550.0% | +56.7% |
- ORTHOPEDIATRICS CORP showed a decrease of -3.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, ORTHOPEDIATRICS CORP’s diluted eps has declined by 79.8% (from $0.94 per share (loss) to $1.69 per share (loss)).
- The most recent figure is from ORTHOPEDIATRICS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: